» Authors » Marc A Mason

Marc A Mason

Explore the profile of Marc A Mason including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 16
Citations 491
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Van Voorhees A, Mason M, Harrold L, Guo N, Guana A, Tian H, et al.
J Dermatolog Treat . 2020 Feb; 32(8):907-915. PMID: 32027197
Objective: Biologic therapies have revolutionized the management of moderate-to-severe psoriasis; however, there are a limited number of US real-world studies characterizing patients based on response to these treatments. This study...
2.
Callis Duffin K, Mason M, Gordon K, Harrison R, Crabtree M, Guana A, et al.
Dermatology . 2020 Jan; 237(1):46-55. PMID: 31962340
Background: Real-world studies evaluating patients with challenging-to-treat localizations of psoriasis (scalp, nail, and palmoplantar) are limited. Objective: To characterize patients with versus without psoriasis in challenging-to-treat areas seen in routine...
3.
Van Voorhees A, Mason M, Harrold L, Guo N, Guana A, Tian H, et al.
J Dermatolog Treat . 2019 Oct; 32(3):302-309. PMID: 31581919
Objective: Biologic therapies have dramatically changed the management of moderate to severe psoriasis; however, few US real-world studies characterize the unmet needs of patients who do not respond to biologic...
4.
Pappas D, Kent J, Greenberg J, Mason M, Kremer J, Holt R
Rheumatol Ther . 2016 Oct; 2(2):153-164. PMID: 27747534
Introduction: The goal of this study was to evaluate how frequently rheumatoid arthritis (RA) therapy is instituted promptly and to describe the characteristics of patients who are not treated early...
5.
Boytsov N, Harrold L, Mason M, Gaich C, Zhang X, Larmore C, et al.
Curr Med Res Opin . 2016 Aug; 32(12):1959-1967. PMID: 27558077
Objective: Determine healthcare resource utilization (HCRU) in biologic-naïve initiators of TNF inhibitors (TNFis) associated with their disease activity from a national cohort of rheumatoid arthritis (RA) patients. Methods: RA patients...
6.
Kuczmarski A, Cotugna N, Mason M, Evans M, Zonderman A
J Caffeine Res . 2015 Mar; 5(1):31-41. PMID: 25785235
Recent research has linked caffeine consumption with a lower risk for depression and cognitive decline. However, no studies have examined the relationship in an African American compared to a white,...
7.
Beydoun M, Fanelli-Kuczmarski M, Kitner-Triolo M, Beydoun H, Kaufman J, Mason M, et al.
Psychosom Med . 2014 Dec; 77(1):68-82. PMID: 25478706
Background: Dietary antioxidants can inhibit reactions accompanying neurodegeneration and thus prevent cognitive impairment. We describe associations of dietary antioxidants with cognitive function in a large biracial population, while testing moderation...
8.
Mason M, Fanelli Kuczmarski M, Allegro D, Zonderman A, Evans M
Public Health Nutr . 2014 Dec; 18(11):1922-31. PMID: 25435191
Objective: Analysing dietary data to capture how individuals typically consume foods is dependent on the coding variables used. Individual foods consumed simultaneously, like coffee with milk, are given codes to...
9.
Cornelis M, Byrne E, Esko T, Nalls M, Ganna A, Paynter N, et al.
Mol Psychiatry . 2014 Oct; 20(5):647-656. PMID: 25288136
Coffee, a major dietary source of caffeine, is among the most widely consumed beverages in the world and has received considerable attention regarding health risks and benefits. We conducted a...
10.
Fanelli Kuczmarski M, Mason M, Beydoun M, Allegro D, Zonderman A, Evans M
J Nutr Gerontol Geriatr . 2013 Nov; 32(4):291-316. PMID: 24224938
The primary objective of this cross-sectional study was to characterize dietary patterns of African Americans and Whites, 30 to 64 years, examined in the Healthy Aging in Neighborhoods of Diversity...